Penumbra, Inc. to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

ALAMEDA, Calif., May 3, 2017 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today announced that its management team is scheduled to present at the Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas, NV

Event:

Bank of America Merrill Lynch 2017 Health Care Conference

Date:

Wednesday, May 17, 2017

Time:

8:00pm ET / 5:00pm PT

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

A webcast of the presentation will be available by visiting the investors section of the company’s website at www.penumbrainc.com. The webcast will be available on the company’s website for two weeks following the event.

About Penumbra 
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on interventional therapies. Penumbra designs, develops, manufactures and markets innovative devices and has a broad portfolio of products that addresses challenging medical conditions and significant clinical needs across two major markets, neuro and peripheral vascular. Penumbra sells its products to hospitals primarily through its direct sales organization in the U.S., most of Europe, Canada and Australia, and through distributors in select international markets. Penumbra and the Penumbra logo are trademarks of Penumbra, Inc.

Investor Relations

Penumbra, Inc.
510-995-2461 
investors@penumbrainc.com 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-bank-of-america-merrill-lynch-2017-health-care-conference-300450884.html

SOURCE Penumbra, Inc.